CLINICAL_TRIALS
trial_result
· 2023-10-19
Clinical Trial Update: Activity of Sorafenib in Salivary Gland Cancer [Phase 2]
Summary
Phase 2 clinical trial update on sorafenib in salivary gland cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Salivary Gland Cancer | Phase 2 | Status: COMPLETED